Levosimendan Altan

Levosimendan, the active ingredient in Levosimendan Altan, is a calcium sensitizer presented as an injectable solution for intravenous use. It treats acute decompensated heart failure and low cardiac output syndrome in hospitalized patients requiring intensive monitoring.

GNH USA supplies Levosimendan Altan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, pharmacies and clinics across multiple regions worldwide, with strict quality assurance and cold‑chain logistics, ensuring product integrity from manufacture to delivery, and providing regulatory support for import compliance and post‑marketing surveillance.

Levosimendan is used in the management of cardiovascular conditions characterized by reduced cardiac output.

Acute decompensated heart failure: improves myocardial contractility and alleviates symptoms of low